Title: Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the
treatment of chronic hepatitis C: the real-world data in China
Version: 2 Date: 30 Oct 2023
Reviewer's report:
The authors addressed required issues.
Title: Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the
treatment of chronic hepatitis C: the real-world data in China
Version: 2 Date: 30 Oct 2023
Reviewer's report:
The authors addressed required issues.
Please review this paper.
user
Title: Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the
treatment of chronic hepatitis C: the real-world data in China
Version: 2 Date: 30 Oct 2023
Reviewer's report:
The authors addressed required issues.
assistant